ReviewExpert opinion on investigational drugs2014

Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia.

Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.